Suspension of trading
Oncternal Therapeutics, Inc. Share Price
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/25/01 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/25/01 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 15.59L 13.7L 12.75L 11.71L 21.99L 15Cr 22.28L 1.52Cr 59.21L 7.38Cr 58.51L 57.25L 26Cr | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -3.24Cr -2.85Cr -2.65Cr -2.43Cr -4.57Cr -310.51Cr -4.63Cr -31Cr -12Cr -153.32Cr -12Cr -12Cr -529.93Cr | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 01/12/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 01/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -92.96% | 15.59L | |
| -0.25% | -0.78% | -0.99% | +10.90% | 4.77TCr | |
| -0.61% | +4.26% | +396.16% | +647.20% | 4TCr | |
| 0.00% | +4.93% | +11.81% | +55.56% | 3.62TCr | |
| +2.48% | +4.57% | +7.05% | -5.05% | 3.56TCr | |
| +0.62% | +3.53% | +5.41% | +42.19% | 2.79TCr | |
| -0.17% | +0.66% | - | - | 1.67TCr | |
| -2.00% | +11.64% | +31.71% | +136.81% | 1.65TCr | |
| +0.06% | -3.88% | +2.35% | +7.45% | 1.32TCr | |
| +1.82% | +1.56% | -9.75% | -30.15% | 1.29TCr | |
| Average | -1.33% | -0.09% | +49.31% | +85.77% | 2.47TCr | |
| Weighted average by Cap. | +1.34% | +2.94% | +74.11% | +136.35% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 14.9L 13.1L 12.19L 11.2L 21.03L 14Cr 21.3L 1.45Cr 56.61L 7.06Cr 55.93L 54.73L 24Cr | 8L 7L 6L 6L 11.08L 7.53Cr 11.22L 76.36L 29.82L 3.72Cr 29.47L 28.83L 13Cr |
| Net income | -4.42Cr -3.88Cr -3.61Cr -3.32Cr -6.23Cr -423.59Cr -6.32Cr -43Cr -17Cr -209.16Cr -17Cr -16Cr -722.93Cr | -3.95Cr -3.47Cr -3.23Cr -2.97Cr -5.57Cr -378.6Cr -5.64Cr -38Cr -15Cr -186.95Cr -15Cr -15Cr -646.15Cr |
| Net Debt | -6.36Cr -5.59Cr -5.21Cr -4.78Cr -8.98Cr -610.27Cr -9.1Cr -62Cr -24Cr -301.34Cr -24Cr -23Cr -1.04TCr | -3.39Cr -2.98Cr -2.78Cr -2.55Cr -4.79Cr -325.45Cr -4.85Cr -33Cr -13Cr -160.7Cr -13Cr -12Cr -555.44Cr |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
